UK cost of cancer drugs one of the lowest in Europe
Compared to other high-income countries, the UK pays less for cancer drugs, according to a report in the Lancet journal.
Germany, Sweden and Switzerland pay the most for the same drugs. The price of cancer drugs has risen sharply in recent years — accounting for over £10 billion of EU healthcare spending in 2013 – but David Watson, director of pricing and reimbursement at the Association of the British Pharmaceutical Industry said the UK is “getting a fair deal with regards to medicines pricing”. The authors of the study say transparency is needed as some countries risk overpaying for drugs; in the higher paying countries the price was sometimes twice as high.
Or.. you can begin your anticancer health regimen today.